Monday, October 26, 2026 · Daily editionET --:--:--

Under way, not recruiting

Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation

NCT06814093 · Xu jianmin · Updated 9 May 2025

What is being tested
Robotic surgery; Laparoscopic surgery
For
Rectal Cancer
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 2,702 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 Jan 2021, ends 30 April 2025. Registered 7 Feb 2025.
Results
None posted yet.

In the researchers' words

This study aims to compare the effectiveness of robotic surgery versus laparoscopic surgery in treating low rectal cancer. While robotic surgery has gained popularity, there is limited long-term evidence regarding its outcomes. By using real-world data from a specialized multicenter colorectal cancer database in Shanghai, China, this retrospective cohort study will emulate the target trial to evaluate whether robotic surgery offers advantages over laparoscopic surgery. Key factors such as disease-free survival, locoregional recurrence, circumferential margin positivity, and postoperative complications will be examined. The goal is to provide stronger, evidence-based support for the clinical use of robotic surgery in treating low rectal cancer.
ClinicalTrials.gov, NCT06814093

Sites

  • Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai, Shanghai Municipality, China